Diabetes Mellitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Diabetes Mellitus 2. HbA1c level is within a range of 5.2-7.5% 3. Written informed consent 4. Ability of using smartphone or getting assist to use it
Exclusion criteria
Exclusion criteria: 1. Malignant hypertension or secondary hypertension 2. Necessity of treatment by insulin 3. Pregnancy or potentialities pregnancy 4. Severe renal dysfunction (eGFR<45ml/min/1.73^2) 5. Severe hepatic dysfunction 6. Under the treatment or within 3 months outbreak of myocardial infarction or cerebrovascular disease 7. Sever allergy or taking steroid 8. chronic pancreatitis 9. Under the treatment of malignancy 10. Patients ineligible for the study determined by doctors
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood HbA1c level in the end | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.fasting blood glucose 2.expenditure 3.body mass index 4.blood pressure 5.lipid metabolism (TCHO,TG,LDL-C,HDL-C) 6.urinary albumin 7.diabetic complication state 8.medication changing during the trial 9.frequency of application use | — |
Countries
Japan
Contacts
Kanazawa University Hospital Internal medicine of Endocrinology and Metabolism